Using fat free mass, decreasing contrast over-enhancement by 47%
Discover the innovative approach taken on contrast management by Group 3R, a private group of 13 imaging centers across Switzerland. In addition to increasing their patients in the target enhancement range from 20 to 62%, that resulted in a reduction of contrast over-enhancement from 79% to 32%. Combined with the partnership of GE's digital adoption team, we'll look into how to leverage machine learning algorithms to improve results even further.
Learn more at www.gehealthcare.com/products/dose-management/dosewatch-dose-monitoring-software-ge-healthcare